6th International Conference on Molecular Neurodegeneration

May 21-23, 2020  •  Bangkok, Thailand

The prevalence of age-related neurodegenerative diseases is rapidly increasing whilst effective treatment and prevention strategies still need to be established. The urgency to discover risk-associated and causative molecular mechanisms to improve our understanding of the pathogenesis of these disorders is therefore high.

Accumulating evidence including recent cutting-edge discoveries propose both disease-specific and disease-overlapping roles of glial cells in the pathophysiology of neurodegenerative diseases. Furthermore, regulation and function of the cerebrovasculature, blood-flow and the integrity of the blood-brain-barrier are frequently affected in neurodegenerative conditions.

The 6th International Conference on Molecular Neurodegeneration (ICMN2020) will offer a series of invited talks by well-renowned speakers to discuss Glial and Vascular Contributions to Neurodegenerative Diseases. The combination of invited talks with abstract-selected short talks and poster presentations will provide excellent opportunities for productive discussions, networking, and collaboration to further our understanding on the genetic, cell and molecular processes responsible for the most common neurodegenerative disorders.

Save the date and join us at ICMN2020 in Bangkok, Thailand on May 21-23 2020!

 

ICMN2020 Organizing Committee
(Guojun Bu, Henrietta Nielsen, Robert Vassar, Huaxi Xu, Hui Zheng)

Organized by:

Partner:

:

 

ICMN2020 THEME

Glial and Vascular Contributions to Neurodegenerative Diseases

Neurodegenerative diseases collectively refer to neurological disorders that result from neurodegeneration and include, but are not limited to, Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, and prion diseases. These diseases, which are often associated with advanced aging and display varying degrees of dementia, have become a significant public health issue as humans live longer and the aging population grows larger. Recent advances in the molecular and cellular mechanisms underlying the pathogenesis of these neurodegenerative disorders have allowed for a better understanding of the disease mechanisms.

MOLECULAR NEURODEGENERATION

The conference is organized by Molecular Neurodegeneration,

the leading peer-reviewed open access journal in the neuroscience category and the official journal of the BrightFocus Foundation.

Molecular Neurodegeneration is an open access, peer-reviewed journal that encompasses all aspects of neurodegeneration research at the molecular and cellular levels.

ORGANIZING COMMITTEE

Guojun Bu (Molecular Neurodegeneration co-editor in chief) 
Mayo Clinic FL, USA
 
Henrietta Nielsen (Molecular Neurodegeneration senior editor)
Stockholm University, Sweden
 
Robert Vassar (Molecular Neurodegeneration associate editor)
Northwestern University Medical School, USA.
 
Huaxi Xu (Molecular Neurodegeneration co-editor in chief)
Sanford Burnham Prebys Medical Discovery Institute, USA
 
Hui Zheng (Molecular Neurodegeneration associate editor)
Baylor College of Medicine, USA

Review Organizing Committee bios here.

SESSIONS

The event will consist of guest podium presentations, panel discussions and selected poster presentations.  

The abstract submission platform will open later this winter.  

MEETING AT-A-GLANCE

AGENDA - DAY 1

THURSDAY, May 21
07:30 REGISTRATION
08:30 WELCOME REMARKS
08:45 SESSION I: Glial Contributions to Neurodegeneration
10:25 COFFEE BREAK/EXHIBITS
10:45 SESSION II: Genomic and Functional Studies of Glia
12:25 LUNCH/EXHIBITS
13:45 SESSION III: Novel Systems and Approaches
15:25 BREAK/EXHIBITS
15:45 SHORT TALKS I
16:35 SHORT TALKS II
17:15 PANEL DISCUSSION
18:15 POSTERS/RECEPTION

AGENDA - DAY 2

FRIDAY, May 22
07:30 REGISTRATION
08:30 SESSION IV: ApoE and Vascular Contributions to Neurodegeneration
10:10 BREAK/EXHIBITS
10:30 SESSION V: Pathogenic Mechanisms of Neurodegeneration (AD and ADRD)
12:35 LUNCH/EXHIBITS
14:00 SESSION VI: Pathogenic Mechanisms of Neurodegeneration (PD and ALS)
15:40 BREAK/EXHIBITS
16:00 SHORT TALKS
17:30 PANEL DISCUSSION
18:30 POSTER SESSION

AGENDA - DAY 3

SATURDAY, May 23
07:30 Registration
08:30 SESSION VII: Neuropathology & Clinical Insights
9:45 BREAK/EXHIBITS
10:05 SESSION VIII: Therapeutic Approaches
11:20 AWARDS
11:35 Short talk/poster awards/closing
12:05 LUNCH and NETWORKING

COUNTDOWN TO ABSTRACT OPENING

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

COUNTDOWN TO CONFERENCE

Day(s)

:

Hour(s)

:

Minute(s)

:

Second(s)

IMPORTANT DEADLINES

Abstract submission opens December 9, 2019
Abstract submission closes January 27, 2020
Notification of abstract acceptance on or around February 15, 2020
Early-bird registration ends February 28, 2020

2018 GALLERY